PriceTargets.com logo

RUA Life Sciences - RUA Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 11.67 As of 12/4/2025 10:51 AM ET
▼ -0.33 (-2.75%)

This chart shows the closing price for RUA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New RUA Life Sciences Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RUA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RUA

Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for RUA Life Sciences in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 11.67.

This chart shows the closing price for RUA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in RUA Life Sciences. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/13/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/11/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/10/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/8/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/6/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/5/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/19/2022Shore CapitalReiterated RatingSuspended
12/13/2021Shore CapitalReiterated RatingHouse Stock
11/3/2021Shore CapitalReiterated RatingHouse Stock
8/31/2021Shore CapitalReiterated RatingHouse Stock
7/12/2021Shore CapitalReiterated RatingHouse Stock
6/25/2021Shore CapitalReiterated RatingHouse Stock
5/10/2021Shore CapitalReiterated RatingHouse Stock
(Data available from 12/5/2020 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/9/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/8/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/8/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/7/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/6/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/6/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/5/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/5/2025

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
RUA Life Sciences logo
The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.
Read More

Today's Range

Now: GBX 11.67
Low: 11.67
High: 12.44

50 Day Range

MA: GBX 11.69
Low: 10.72
High: 13.28

52 Week Range

Now: GBX 11.67
Low: 10.33
High: 14.50

Volume

61,704 shs

Average Volume

145,095 shs

Market Capitalization

£7.24 million

P/E Ratio

N/A

Dividend Yield

1.44%

Beta

1.21

Frequently Asked Questions

What sell-side analysts currently cover shares of RUA Life Sciences?

The following Wall Street research analysts have issued research reports on RUA Life Sciences in the last twelve months:
View the latest analyst ratings for RUA.

What is the current price target for RUA Life Sciences?

0 Wall Street analysts have set twelve-month price targets for RUA Life Sciences in the last year. has the lowest price target set, forecasting a price of £100,000 for RUA Life Sciences in the next year.
View the latest price targets for RUA.

What is the current consensus analyst rating for RUA Life Sciences?

RUA Life Sciences currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for RUA.

What other companies compete with RUA Life Sciences?

Other companies that are similar to RUA Life Sciences include Novacyt, Inspiration Healthcare Group, Advanced Oncotherapy, Surgical Innovations Group and MyHealthChecked. Learn More about companies similar to RUA Life Sciences.

How do I contact RUA Life Sciences' investor relations team?

RUA Life Sciences' physical mailing address is 2 Drummond Crescent, Irvine, Ayrshire KA11 5AN, United Kingdom. The company's listed phone number is 44 1294 317073. The official website for RUA Life Sciences is www.rualifesciences.com. Learn More about contacing RUA Life Sciences investor relations.